Black women experience longer breast cancer treatment times and may have less access to essential radiation technology, according to a study published in Cancer.
The FDA Oncologic Drugs Advisory Committee July 25 voted unanimously to set more rigorous standards for new trials for approval of perioperative indications of cancer drugs.
